Scholarlink

Background <p>The PAX7::FOXO1 subtype of alveolar rhabdomyosarcoma (aRMS) is both understudied and an unmet clinical need. The biology of PAX7::FOXO1 aRMS is significantly different than PAX3::FOXO1 aRMS, presenting an opportunity to gain biological, clinical and therapeutic insights by murine genetic modeling of <i>Pax7::Foxo1</i> for comparison to the existing conditional genetic mouse model of <i>Pax3::Foxo1</i> aRMS.</p> Methods <p>Using gene targeting, a mouse strain harboring a Cre-LoxP activated conditional knock-in of <i>Pax7::Foxo1</i> targeted to the murine <i>Pax7</i> locus has been generated.</p> Results <p>Activation of the conditional knock-in of <i>Pax7::Foxo1</i> allele in the prenatal <i>Pax7</i> lineage recapitulates the birth defects (stunting and maxillofacial deformities) known for the conditional knock-in of <i>Pax3::Foxo1</i> allele. Activation of the conditional knock-in of <i>Pax7::Foxo1</i> allele in the prenatal <i>Myf6</i> lineage is viable, fertile, and results in ongoing expression from <i>Pax7</i> promoter in myofibers.</p> Conclusions <p>This mouse strain is a resource for the rhabdomyosarcoma research community to explore lineage (cell) of origin, to define sufficiency for tumor initiation or the necessity of cooperative tumor initiating mutations, to uncover the biology of the PAX7::FOXO1 subtype of alveolar rhabdomyosarcoma, and to test therapies including immunotherapies.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

A Pax7::Foxo1 conditional mouse strain

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月27日

查看全文
  • G. Roger Askew,
  • Jonathan Gauntlett,
  • Katherine Brechun,
  • Harald Kranz,
  • Nicholas Salters,
  • Jess D. Tate,
  • Ellen Wang,
  • Cassie Badger,
  • Shireen Elhabian,
  • Jared Schnider,
  • Gillian St. John,
  • Samuel V. Rasmussen,
  • Narendra Bharathy,
  • Charles Keller

摘要

Background

The PAX7::FOXO1 subtype of alveolar rhabdomyosarcoma (aRMS) is both understudied and an unmet clinical need. The biology of PAX7::FOXO1 aRMS is significantly different than PAX3::FOXO1 aRMS, presenting an opportunity to gain biological, clinical and therapeutic insights by murine genetic modeling of Pax7::Foxo1 for comparison to the existing conditional genetic mouse model of Pax3::Foxo1 aRMS.

Methods

Using gene targeting, a mouse strain harboring a Cre-LoxP activated conditional knock-in of Pax7::Foxo1 targeted to the murine Pax7 locus has been generated.

Results

Activation of the conditional knock-in of Pax7::Foxo1 allele in the prenatal Pax7 lineage recapitulates the birth defects (stunting and maxillofacial deformities) known for the conditional knock-in of Pax3::Foxo1 allele. Activation of the conditional knock-in of Pax7::Foxo1 allele in the prenatal Myf6 lineage is viable, fertile, and results in ongoing expression from Pax7 promoter in myofibers.

Conclusions

This mouse strain is a resource for the rhabdomyosarcoma research community to explore lineage (cell) of origin, to define sufficiency for tumor initiation or the necessity of cooperative tumor initiating mutations, to uncover the biology of the PAX7::FOXO1 subtype of alveolar rhabdomyosarcoma, and to test therapies including immunotherapies.